Industry reports
Editor highlights

Colorectal Cancer France Drug Forecasts and Treatment Analysis to 2020

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Global Hormone Replacement Therapy (HRT) Industry

Global Hormone Replacement Therapy (HRT) Industry

  • $ 4 950
  • Industry report
  • by Global Industry Analysts
  • January 2014
  • 180 pages

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. ...

Industries: Therapy | Countries: World, United States, Canada, Europe, United Kingdom, France, Italy, Germany, Spain, North America, Japan

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2011 - 2020)

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2011 - 2020)

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • December 2013
  • 157 pages

The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential as the incidence rate of the disease is increasing all over the globe. The incidence of acute lymphocytic/lymphoblastic leukemia is higher in children from 0 to 14 years than in those aged 15 years and above. However, ...

Industries: Therapy | Countries: Canada, Spain, Italy, France, Germany, Japan, United States, Europe, World, North America

Hyperuricemia - Pipeline Review, H2 2013

Hyperuricemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • November 2013
  • 51 pages

Hyperuricemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hyperuricemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hyperuricemia, complete with latest updates, and special ...

Industries: Therapy | Countries: World, Japan, Canada, France, South Korea

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation

  • $ 3 500
  • Industry report
  • by GBI Research
  • October 2013
  • 90 pages

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation Summary GBI Research has released its pharmaceuticals report, "Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying ...

Industries: Therapy | Countries: World, Japan, United States, Spain, Italy, France, Germany

Ion Beam Applications S.A. (Symbol:IBAB) SWOT Analysis, Strategy, Revenues and Profits

Ion Beam Applications S.A. (Symbol:IBAB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • June 2013
  • 40 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Ion Beam Applications S.A. SWOT Analysis report provides you a strategic ...

Industries: Therapy | Countries: United States, France, Belgium

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 8 995
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • June 2013

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, Europe, France, United States, Netherlands, Spain, Italy, Germany, World, United Kingdom, Denmark

PX%Therapeutics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PX%Therapeutics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2013
  • 18 pages

Summary PX'Therapeutics SA (PX'Therapeutics) is a biotechnology company, based in France. The company develops the biotherapeutics from early stage research up to GMP (Good Manufacturing Practices) production of clinical grade material. It offers contract research services focusing on the engineering ...

Industries: Therapy | Countries: France

Ark Therapeutics Group plc (Symbol:AKT) SWOT Analysis, Strategy, Revenues and Profits

Ark Therapeutics Group plc (Symbol:AKT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • May 2013
  • 39 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Ark Therapeutics Group plc SWOT Analysis report provides you a strategic ...

Industries: Therapy | Countries: France, Finland

ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment

ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment

  • $ 3 500
  • Industry report
  • by GBI Research
  • April 2013
  • 66 pages

ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment Summary GBI Research, the leading business intelligence provider, has released its latest research ?ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offe ...

Industries: Therapy | Countries: Spain, Japan, Italy, France, Germany, Europe, United States, United Kingdom, World

Treatment Algorithms: Postherpetic Neuralgia - Lyrica forms the cornerstone of treatment for postherpetic neuralgia

Treatment Algorithms: Postherpetic Neuralgia - Lyrica forms the cornerstone of treatment for postherpetic neuralgia

  • $ 7 600
  • Industry report
  • by Datamonitor
  • November 2012
  • 88 pages

Prescribing trends reveal that patients with PHN are typically initiated on monotherapy. Since no single therapy provides sufficient efficacy, physicians increasingly turn to combination therapy at later lines of treatment to optimize patient outcomes. Lyrica (pregabalin; Pfizer) leads the market, with ...

Industries: Therapy | Countries: Spain, United States, United Kingdom, Italy, France, Germany, Japan

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.